Although the guidance for diagnosis and management of diabetic ketoacidosis is usually well documented, EDKA is relatively less known and indeed a unique phenomenon associated with the introduction and usage of SGLT-2 inhibitors. This evidence concerns the gene SLC5A2 and diabetic ketoacidosis.